Your browser doesn't support javascript.
loading
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
Suwala, Abigail K; Stichel, Damian; Schrimpf, Daniel; Kloor, Matthias; Wefers, Annika K; Reinhardt, Annekathrin; Maas, Sybren L N; Kratz, Christian P; Schweizer, Leonille; Hasselblatt, Martin; Snuderl, Matija; Abedalthagafi, Malak Sameer J; Abdullaev, Zied; Monoranu, Camelia M; Bergmann, Markus; Pekrun, Arnulf; Freyschlag, Christian; Aronica, Eleonora; Kramm, Christof M; Hinz, Felix; Sievers, Philipp; Korshunov, Andrey; Kool, Marcel; Pfister, Stefan M; Sturm, Dominik; Jones, David T W; Wick, Wolfgang; Unterberg, Andreas; Hartmann, Christian; Dodgshun, Andrew; Tabori, Uri; Wesseling, Pieter; Sahm, Felix; von Deimling, Andreas; Reuss, David E.
  • Suwala AK; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Stichel D; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Schrimpf D; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Kloor M; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Wefers AK; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Reinhardt A; Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Maas SLN; Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kratz CP; Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Schweizer L; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Hasselblatt M; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Snuderl M; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Abedalthagafi MSJ; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Abdullaev Z; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Monoranu CM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Bergmann M; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Pekrun A; Department of Neuropathology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.
  • Freyschlag C; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Aronica E; Institute of Neuropathology, University Hospital Münster, Münster, Germany.
  • Kramm CM; Division of Neuropathology, NYU Langone Health, New York, USA.
  • Hinz F; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, USA.
  • Sievers P; Division of Molecular Pathology and Diagnostics, NYU Langone Health, New York, USA.
  • Korshunov A; Pathology Department, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Kool M; Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City and King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.
  • Pfister SM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Sturm D; Institute of Pathology, Julius-Maximilians-University, Würzburg, Germany.
  • Jones DTW; Institute of Clinical Neuropathology, Bremen-Mitte Medical Center, Bremen, Germany.
  • Wick W; Professor Hess Children's Hospital, Klinikum Bremen-Mitte, Bremen, Germany.
  • Unterberg A; Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria.
  • Hartmann C; Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Dodgshun A; Division of Pediatric Hematology and Oncology, University Medical Center Goettingen, Goettingen, Germany.
  • Tabori U; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Wesseling P; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Sahm F; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • von Deimling A; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Reuss DE; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Acta Neuropathol ; 141(1): 85-100, 2021 01.
Article en En | MEDLINE | ID: mdl-33216206

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Astrocitoma / Neoplasias Encefálicas / Reparación de la Incompatibilidad de ADN / Isocitrato Deshidrogenasa Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Astrocitoma / Neoplasias Encefálicas / Reparación de la Incompatibilidad de ADN / Isocitrato Deshidrogenasa Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article